Actinium Completes Technology Transfer for Manufacturing of Its Lead Drug Candidate Iomab™-B Dec 19, 2013
Actinium Pharmaceuticals Announces Clinical Advisory Board Meeting At The 2013 ASH Conference Dec 9, 2013
Encouraging Clinical Data From Multicenter Phase 1/2 Trial On Actinium's Actimab-A Presented At American Society Of Hematology Annual Meeting Dec 9, 2013
Actinium Pharmaceuticals Announces Additional Clinical Data From Multicenter Phase 1/2 Trial on Actinium's Actimab-A to Be Presented at American Society of Hematology Annual Meeting Dec 2, 2013
Actinium Pharmaceuticals Announces Plans For Iomab™-B Phase 3 Pivotal Trial Following Meeting With FDA Nov 18, 2013
